oncology
Medical debt linked to late stage cancers
Medical debt is linked to higher late-stage cancer diagnoses, including lung cancer cases per 100,000 person-years.
New Treatment Improves Survival in First-Line Small Cell Lung Cancer
New treatment improves survival in first-line small cell lung cancer with a combination of tarlatamab and durvalumab, showing a significant clinical benefit.
Hospitals struggle with high costs of CAR T-cell therapy programs
Hospitals face steep CAR T-cell therapy costs, from drug pricing to staffing and safety protocols, straining smaller clinics and outpatient programs.
FDA approves Camizestrant for breast cancer with ESR1 mutations
The FDA approves camizestrant for ER-positive, HER2-negative metastatic breast cancer with ESR1 mutations. Learn about this new treatment option and its clinica
Mountain West Cancer Care Hampered by Distance, Telehealth
Cancer telehealth is bridging the vast distance barrier for Mountain West patients, offering remote specialist access and reducing travel hardships.
FDA approves Rusfertide for erythrocytosis in polycythemia vera
FDA approves rusfertide (Mimrylo) for erythrocytosis, sparing polycythemia vera patients from painful phlebotomies. Read the latest medical news.
CAR T Cell Therapy Gets New Guidelines
CAR T cell therapy gets new guidelines to protect patients and ensure safe delivery, reflecting advancements in the field of cancer treatment.
Global Study Assesses Leukemia Care Needs
Global study reveals significant challenges in managing leukemia therapies and care capabilities across different countries and clinical settings.